P3 Health Partners (PIII) Return on Equity (2021 - 2025)
P3 Health Partners (PIII) has disclosed Return on Equity for 5 consecutive years, with 7.15% as the latest value for Q2 2025.
- For the quarter ending Q2 2025, Return on Equity fell 622.0% year-over-year to 7.15%, compared with a TTM value of 7.15% through Jun 2025, down 622.0%, and an annual FY2022 reading of 11.69%, changed N/A over the prior year.
- Return on Equity was 7.15% for Q2 2025 at P3 Health Partners, down from 5.37% in the prior quarter.
- Across five years, Return on Equity topped out at 36.72% in Q1 2022 and bottomed at 980.26% in Q1 2023.
- Average Return on Equity over 5 years is 73.89%, with a median of 4.66% recorded in 2021.
- The sharpest move saw Return on Equity crashed -101698bps in 2023, then surged 97926bps in 2024.
- Year by year, Return on Equity stood at 0.6% in 2021, then plummeted by -6301bps to 37.21% in 2022, then soared by 33bps to 25.09% in 2023, then soared by 96bps to 0.94% in 2024, then crashed by -665bps to 7.15% in 2025.
- Business Quant data shows Return on Equity for PIII at 7.15% in Q2 2025, 5.37% in Q1 2025, and 0.94% in Q2 2024.